Eli Lilly: The Bar Just Got Higher (NYSE:LLY)

한겨레

Left

Factuality

Ownership

U.S. pharmaceutical company Eli Lilly announced that its third-quarter revenue increased by 39%, driven by a surge in demand for obesity treatments. In an earnings report released on the 29th (local time), Lilly stated that third-quarter revenue reached $24.4 billion (approximately 32.6 trillion won), a 39% increase compared to the same period last year. Regarding this year's annual revenue forecast...

연합뉴스-Yonhap News Agency

Lean Right

Factuality

Ownership

(Seoul = Yonhap News) Reporter Jung Joo-ho = U.S. pharmaceutical company Eli Lilly announced on the 29th (local time) that its third-quarter sales increased by 39%, driven by a surge in demand for obesity treatments...

ddaily.co.kr

Factuality

Ownership

[Digital Daily Reporter Wang Jin-hwa] The growth of the obesity treatment market is even changing the market capitalization rankings of global companies. U.S. pharmaceutical company Eli Lilly recorded double-digit revenue growth in the third quarter, driven by expanded sales of its flagship treatments, Maunzaro and Zebbound, and surpassed Samsung Electronics to rank 12th in global market capitalization. On the 29th (local time), Eli Lilly disc…